Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Vasopressin and Epinephrine Versus Epinephrine Alone in Cardiac Arrest
This study has been completed.
Study NCT00127907 Information provided by Hospices Civils de Lyon
First Received: August 5, 2005 Last Updated: October 16, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cardiac Arrest
Additional conditions recognized in this trial
Heart Arrest
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Interventions listed in this trial
epinephrine (1 mg/1 mL)
arginine-vasopressin (40 UI/2 mL)
Additional drug interventions recognized in this trial
Arginine Vasopressin
Epinephrine
Vasopressins
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-Agonists
Adrenergic beta-Agonists
Anti-Asthmatic Agents
Antidiuretic Agents
Autonomic Agents
Bronchodilator Agents
Cardiovascular Agents
Coagulants
Hematologic Agents
Hemostatics
Molecular Mechanisms of Pharmacological Action
Mydriatics
Natriuretic Agents
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Sympathomimetics
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
Hospices Civils de Lyon
Back to top of Main Content